Forget weight loss, baldness reversal is Wall Street’s next big bet
- Investors are shifting focus to baldness treatments, with the global market potential estimated at $3 bn.
- Pattern hair loss affects an estimated 50 million men and 30 million women in the US, but there have been no new approved drugs since the late 1990s.
- Shares of Veradermics Inc. which promise novel treatments addressing baldness have surged nearly 500% since Feb'26.
- Bloomberg analysts are positive about both the markets and companies.
Source: fortune.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
